Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model-Reference-Cited by-同舟云学术

Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model

Published:2016-06-17 Issue:6 Volume:11 Page:e0157757
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Fan Bing,Guan Jie,Wang Xiumei,Cong Yulong

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Global challenge of multidrug-resistant Acinetobacter baumannii;F Perez;Antimicrob Agents Chemother,2007

2. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options;LL Maragakis;Clin Infect Dis,2008

3. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance;AP Magiorakos;Clin Microbiol Infect,2012

4. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia;YC Chuang;Clin Infect Dis,2011

5. Colistin: an update on the antibiotic of the 21st century;S Biswas;Expert Rev Anti Infect Ther,2012

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination therapy with IV fosfomycin for adult patients with serious Gram-negative infections: a review of the literature;Journal of Antimicrobial Chemotherapy;2024-08-31

2. In-vitro evaluation of different antimicrobial combinations with and without colistin against carbapenem-resistant Acinetobacter baumannii clinical isolates;European Journal of Medical Research;2024-06-16

3. Molecular Characteristics of Colistin Resistance in Acinetobacter baumannii and the Activity of Antimicrobial Combination Therapy in a Tertiary Care Medical Center in Lebanon;Microorganisms;2024-02-08

4. Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model;Antimicrobial Agents and Chemotherapy;2023-10-18

5. How to treat severe Acinetobacter baumannii infections;Current Opinion in Infectious Diseases;2023-09-26